CC BY-NC-ND 4.0 · Journal of Fetal Medicine 2018; 05(01): 31-36
DOI: 10.1007/s40556-017-0146-y
Review Article

Screening for Preeclampsia

1   Department of Obstetrics and Gynecology, Army Hospital Research and Referral, 110010, Delhi, Cantt, India
,
K. Aparna Sharma
2   Department of Obstetrics and Gynecology, AIIMS, Delhi, India
› Author Affiliations

Abstract

Pre-eclampsia, still continues to be a major cause of maternal and fetal morbidity and mortality, inspite of being an active area of research. The importance of early prediction of pre-eclampsia lies in the fact that it allows for timely initiation of preventive therapy. A combination of biophysical and biochemical markers are superior to other tests for early prediction of the development of pre-eclampsia. With the inversion of pyramid of antenatal care, preeclampsia screening in the first trimester needs to become the standard of care. Researchers now talk of predicting preeclampsia even in the third trimester to increase surveillance.



Publication History

Received: 16 October 2017

Accepted: 10 November 2017

Article published online:
08 May 2023

© 2017. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India